1	Long-term	long-term	JJ	JJ	_	4	amod	_	_
2	Helicobacter	Helicobacter	NNP	NNP	_	4	nn	_	_
3	pylori	pylori	NN	NN	_	4	nn	_	_
4	infection	infection	NN	NN	_	0	ROOT	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	the	the	DT	DT	_	7	det	_	_
7	development	development	NN	NN	_	4	conj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	atrophic	atrophic	JJ	JJ	_	10	amod	_	_
10	gastritis	gastritis	NN	NN	_	8	pobj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	gastric	gastric	JJ	JJ	_	13	amod	_	_
13	cancer	cancer	NN	NN	_	10	conj	_	_
14	in	in	IN	IN	_	7	prep	_	_
15	Japan	Japan	NNP	NNP	_	14	pobj	_	_
16	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	incidence	incidence	NN	NN	_	13	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	gastric	gastric	JJ	JJ	_	5	amod	_	_
5	cancer	cancer	NN	NN	_	3	pobj	_	_
6	and	and	CC	CC	_	2	cc	_	_
7	the	the	DT	DT	_	8	det	_	_
8	prevalence	prevalence	NN	NN	_	2	conj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	Helicobacter	Helicobacter	NNP	NNP	_	11	nn	_	_
11	pylori	pylori	NNP	NNP	_	9	pobj	_	_
12	are	be	VBP	VBP	_	13	cop	_	_
13	high	high	JJ	JJ	_	0	ROOT	_	_
14	in	in	IN	IN	_	13	prep	_	_
15	Japan	Japan	NNP	NNP	_	14	pobj	_	_
16	,	,	,	,	_	13	punct	_	_
17	so	so	IN	IN	_	22	mark	_	_
18	it	it	PRP	PRP	_	22	nsubj	_	_
19	is	be	VBZ	VBZ	_	22	cop	_	_
20	an	a	DT	DT	_	22	det	_	_
21	important	important	JJ	JJ	_	22	amod	_	_
22	issue	issue	NN	NN	_	13	advcl	_	_
23	whether	whether	IN	IN	_	28	mark	_	_
24	long-term	long-term	JJ	JJ	_	27	amod	_	_
25	H.	h.	NN	NN	_	27	nn	_	_
26	pylori	pylori	NN	NN	_	27	nn	_	_
27	infection	infection	NN	NN	_	28	nsubj	_	_
28	leads	lead	VBZ	VBZ	_	22	ccomp	_	_
29	to	to	TO	TO	_	28	prep	_	_
30	chronic	chronic	JJ	JJ	_	32	amod	_	_
31	atrophic	atrophic	JJ	JJ	_	32	amod	_	_
32	gastritis	gastritis	NN	NN	_	29	pobj	_	_
33	,	,	,	,	_	32	punct	_	_
34	considered	consider	VBN	VBN	_	32	vmod	_	_
35	one	one	CD	CD	_	34	dobj	_	_
36	of	of	IN	IN	_	35	prep	_	_
37	the	the	DT	DT	_	38	det	_	_
38	precursors	precursor	NNS	NNS	_	36	pobj	_	_
39	of	of	IN	IN	_	38	prep	_	_
40	gastric	gastric	JJ	JJ	_	41	amod	_	_
41	cancer	cancer	NN	NN	_	39	pobj	_	_
42	.	.	.	.	_	13	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	reported	report	VBN	VBN	_	0	ROOT	_	_
4	that	that	IN	IN	_	10	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	grade	grade	NN	NN	_	10	nsubj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	atrophy	atrophy	NN	NN	_	7	pobj	_	_
9	was	be	VBD	VBD	_	10	cop	_	_
10	higher	higher	JJR	JJR	_	3	ccomp	_	_
11	in	in	IN	IN	_	10	prep	_	_
12	H.	H.	NNP	NNP	_	14	nn	_	_
13	pylori-positive	pylori-positive	JJ	JJ	_	14	amod	_	_
14	subjects	subject	NNS	NNS	_	11	pobj	_	_
15	than	than	IN	IN	_	10	prep	_	_
16	in	in	IN	IN	_	15	pcomp	_	_
17	H.	H.	NNP	NNP	_	19	nn	_	_
18	pylori-negative	pylori-negative	JJ	JJ	_	19	amod	_	_
19	subjects	subject	NNS	NNS	_	16	pobj	_	_
20	.	.	.	.	_	3	punct	_	_

1	It	it	PRP	PRP	_	5	nsubjpass	_	_
2	has	have	VBZ	VBZ	_	5	aux	_	_
3	also	also	RB	RB	_	5	advmod	_	_
4	been	be	VBN	VBN	_	5	auxpass	_	_
5	reported	report	VBN	VBN	_	0	ROOT	_	_
6	that	that	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	8	det	_	_
8	atrophy	atrophy	NN	NN	_	6	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	gastric	gastric	JJ	JJ	_	11	amod	_	_
11	mucosa	mucosa	NN	NN	_	9	pobj	_	_
12	increased	increase	VBN	VBN	_	8	vmod	_	_
13	in	in	IN	IN	_	12	prep	_	_
14	H.	H.	NNP	NNP	_	16	nn	_	_
15	pylori-infected	pylori-infected	JJ	JJ	_	16	amod	_	_
16	monkeys	monkey	NNS	NNS	_	13	pobj	_	_
17	compared	compare	VBN	VBN	_	8	prep	_	_
18	with	with	IN	IN	_	17	pcomp	_	_
19	control	control	NN	NN	_	20	nn	_	_
20	monkeys	monkey	NNS	NNS	_	18	pobj	_	_
21	in	in	IN	IN	_	20	prep	_	_
22	a	a	DT	DT	_	25	det	_	_
23	5-year	5-year	JJ	JJ	_	25	amod	_	_
24	follow-up	follow-up	JJ	JJ	_	25	amod	_	_
25	study	study	NN	NN	_	21	pobj	_	_
26	.	.	.	.	_	5	punct	_	_

1	Most	most	JJS	JJS	_	4	amod	_	_
2	H.	h.	NN	NN	_	4	nn	_	_
3	pylori	pylori	NN	NN	_	4	nn	_	_
4	infections	infection	NNS	NNS	_	5	nsubj	_	_
5	occur	occur	VBP	VBP	_	0	ROOT	_	_
6	in	in	IN	IN	_	5	prep	_	_
7	children	child	NNS	NNS	_	6	pobj	_	_
8	,	,	,	,	_	5	punct	_	_
9	and	and	CC	CC	_	5	cc	_	_
10	atrophy	atrophy	NN	NN	_	15	nsubj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	the	the	DT	DT	_	14	det	_	_
13	gastric	gastric	JJ	JJ	_	14	amod	_	_
14	mucosa	mucosa	NN	NN	_	11	pobj	_	_
15	progresses	progress	VBZ	VBZ	_	5	conj	_	_
16	during	during	IN	IN	_	15	prep	_	_
17	aging	aging	NN	NN	_	16	pobj	_	_
18	.	.	.	.	_	5	punct	_	_

1	Long-term	long-term	JJ	JJ	_	2	amod	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	show	show	VBP	VBP	_	0	ROOT	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	H.	H.	NNP	NNP	_	7	nn	_	_
6	pylori	pylori	NN	NN	_	7	nn	_	_
7	infection	infection	NN	NN	_	9	nsubj	_	_
8	can	can	MD	MD	_	9	aux	_	_
9	lead	lead	VB	VB	_	3	ccomp	_	_
10	to	to	TO	TO	_	9	prep	_	_
11	gastric	gastric	JJ	JJ	_	12	amod	_	_
12	atrophy	atrophy	NN	NN	_	10	pobj	_	_
13	and	and	CC	CC	_	9	cc	_	_
14	may	may	MD	MD	_	15	aux	_	_
15	play	play	VB	VB	_	9	conj	_	_
16	an	a	DT	DT	_	18	det	_	_
17	important	important	JJ	JJ	_	18	amod	_	_
18	role	role	NN	NN	_	15	dobj	_	_
19	in	in	IN	IN	_	15	prep	_	_
20	the	the	DT	DT	_	21	det	_	_
21	development	development	NN	NN	_	19	pobj	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	gastric	gastric	JJ	JJ	_	24	amod	_	_
24	cancer	cancer	NN	NN	_	22	pobj	_	_
25	.	.	.	.	_	3	punct	_	_

1	Interestingly	interestingly	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	there	there	EX	EX	_	4	expl	_	_
4	was	be	VBD	VBD	_	0	ROOT	_	_
5	no	no	DT	DT	_	6	neg	_	_
6	difference	difference	NN	NN	_	4	nsubj	_	_
7	in	in	IN	IN	_	6	prep	_	_
8	the	the	DT	DT	_	9	det	_	_
9	prevalence	prevalence	NN	NN	_	7	pobj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	H.	H.	NNP	NNP	_	12	nn	_	_
12	pylori	pylori	NN	NN	_	10	pobj	_	_
13	between	between	IN	IN	_	9	prep	_	_
14	patients	patient	NNS	NNS	_	13	pobj	_	_
15	with	with	IN	IN	_	14	prep	_	_
16	chronic	chronic	JJ	JJ	_	17	amod	_	_
17	gastritis	gastritis	NN	NN	_	15	pobj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	gastric	gastric	JJ	JJ	_	20	amod	_	_
20	cancer	cancer	NN	NN	_	17	conj	_	_
21	in	in	IN	IN	_	17	prep	_	_
22	Japan	Japan	NNP	NNP	_	21	pobj	_	_
23	,	,	,	,	_	4	punct	_	_
24	but	but	CC	CC	_	4	cc	_	_
25	the	the	DT	DT	_	26	det	_	_
26	prevalence	prevalence	NN	NN	_	38	nsubj	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	H.	H.	NNP	NNP	_	29	nn	_	_
29	pylori	pylori	NNP	NNP	_	27	pobj	_	_
30	in	in	IN	IN	_	29	prep	_	_
31	young	young	JJ	JJ	_	35	amod	_	_
32	Japanese	japanese	JJ	JJ	_	35	amod	_	_
33	gastric	gastric	JJ	JJ	_	35	amod	_	_
34	cancer	cancer	NN	NN	_	35	nn	_	_
35	patients	patient	NNS	NNS	_	30	pobj	_	_
36	was	be	VBD	VBD	_	38	cop	_	_
37	significantly	significantly	RB	RB	_	38	advmod	_	_
38	higher	higher	JJR	JJR	_	4	conj	_	_
39	than	than	IN	IN	_	38	prep	_	_
40	in	in	IN	IN	_	39	pcomp	_	_
41	the	the	DT	DT	_	43	det	_	_
42	control	control	NN	NN	_	43	nn	_	_
43	group	group	NN	NN	_	40	pobj	_	_
44	.	.	.	.	_	4	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	4	nsubj	_	_
3	clearly	clearly	RB	RB	_	4	advmod	_	_
4	show	show	VBP	VBP	_	0	ROOT	_	_
5	that	that	IN	IN	_	10	mark	_	_
6	H.	H.	NNP	NNP	_	8	nn	_	_
7	pylori	pylori	NN	NN	_	8	nn	_	_
8	infection	infection	NN	NN	_	10	nsubj	_	_
9	is	be	VBZ	VBZ	_	10	cop	_	_
10	one	one	CD	CD	_	4	ccomp	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	the	the	DT	DT	_	14	det	_	_
13	risk	risk	NN	NN	_	14	nn	_	_
14	factors	factor	NNS	NNS	_	11	pobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	gastric	gastric	JJ	JJ	_	17	amod	_	_
17	cancer	cancer	NN	NN	_	15	pobj	_	_
18	in	in	IN	IN	_	14	prep	_	_
19	young	young	JJ	JJ	_	21	amod	_	_
20	Japanese	japanese	JJ	JJ	_	21	amod	_	_
21	people	people	NNS	NNS	_	18	pobj	_	_
22	,	,	,	,	_	10	punct	_	_
23	There	there	EX	EX	_	24	expl	_	_
24	is	be	VBZ	VBZ	_	10	dep	_	_
25	no	no	DT	DT	_	26	neg	_	_
26	answer	answer	NN	NN	_	24	nsubj	_	_
27	to	to	TO	TO	_	26	prep	_	_
28	whether	whether	IN	IN	_	34	mark	_	_
29	curing	cure	VBG	VBG	_	32	amod	_	_
30	H.	H.	NNP	NNP	_	32	nn	_	_
31	pylori	pylori	NN	NN	_	32	nn	_	_
32	infection	infection	NN	NN	_	34	nsubj	_	_
33	can	can	MD	MD	_	34	aux	_	_
34	reverse	reverse	VB	VB	_	27	pcomp	_	_
35	the	the	DT	DT	_	36	det	_	_
36	atrophy	atrophy	NN	NN	_	34	dobj	_	_
37	of	of	IN	IN	_	36	prep	_	_
38	the	the	DT	DT	_	40	det	_	_
39	gastric	gastric	JJ	JJ	_	40	amod	_	_
40	mucosa	mucosa	NN	NN	_	37	pobj	_	_
41	and	and	CC	CC	_	34	cc	_	_
42	decrease	decrease	VB	VB	_	34	conj	_	_
43	the	the	DT	DT	_	44	det	_	_
44	risk	risk	NN	NN	_	42	dobj	_	_
45	of	of	IN	IN	_	44	prep	_	_
46	gastric	gastric	JJ	JJ	_	48	amod	_	_
47	cancer	cancer	NN	NN	_	48	nn	_	_
48	development	development	NN	NN	_	45	pobj	_	_
49	.	.	.	.	_	4	punct	_	_

1	To	to	TO	TO	_	2	aux	_	_
2	clarify	clarify	VB	VB	_	11	advcl	_	_
3	this	this	DT	DT	_	4	det	_	_
4	issue	issue	NN	NN	_	2	dobj	_	_
5	,	,	,	,	_	11	punct	_	_
6	an	a	DT	DT	_	8	det	_	_
7	intervention	intervention	NN	NN	_	8	nn	_	_
8	study	study	NN	NN	_	11	nsubjpass	_	_
9	must	must	MD	MD	_	11	aux	_	_
10	be	be	VB	VB	_	11	auxpass	_	_
11	done	do	VBN	VBN	_	0	ROOT	_	_
12	.	.	.	.	_	11	punct	_	_

1	A	a	DT	DT	_	4	det	_	_
2	large	large	JJ	JJ	_	4	amod	_	_
3	clinical	clinical	JJ	JJ	_	4	amod	_	_
4	trial	trial	NN	NN	_	5	nsubj	_	_
5	called	call	VBD	VBD	_	0	ROOT	_	_
6	the	the	DT	DT	_	9	det	_	_
7	Japanese	japanese	JJ	JJ	_	9	amod	_	_
8	Intervention	intervention	NN	NN	_	9	nn	_	_
9	Trial	trial	NN	NN	_	5	dobj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	H.	H.	NNP	NNP	_	12	nn	_	_
12	pylori	pylori	NNP	NNP	_	10	pobj	_	_
13	is	be	VBZ	VBZ	_	5	dep	_	_
14	in	in	IN	IN	_	13	prep	_	_
15	progress	progress	NN	NN	_	14	pobj	_	_
16	.	.	.	.	_	5	punct	_	_
